Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Neurologic Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Neurologic Other
    MRI Can Predict Outcome of Infants Deficient of Oxygen at Birth - (DGNews)
    Brain Tumours In Childhood Leave a Lasting Mark On Cognition, Life Status - (DGNews)
    Rifaximin Protects Patients With Cirrhosis From Breakthrough Hepatic Encephalopathy Over Long Term: Presented at AASLD - (DGDispatch)
    Neurocognitive Issues Plague HIV-Infected Patients Taking Antiretroviral Therapy: Presented at IDSA - (DGDispatch)
    Vaccine Inoculations Show No Link to Autism, Other Health Problems: Presented at IDSA - (DGDispatch)

    News archive

     Recent webcasts/CME - Neurologic Other
      Therapeutic Hypothermia
      Arteriovenous Malformations Dural Arteriovenous Shunts
      PreAnesthetic Assessment of the Patient with Neurotrauma
      Generalized Convulsive Status Epilepticus Guillain Barre Syndrome
      High-Risk Transient Ischemic Attacks Clinical Uses of Transcranial Doppler

      Webcasts/CME archive

       Recent cases - Neurologic Other
        Giant Thoracic Schwannoma Presenting with Abrupt Onset of Abdominal Pain: A Case Report
        Atypical Imaging Findings in a Renal Transplant Patient with Reversible Posterior Leukoencephalopathy Syndrome: A Case Report
        Reversible Cerebellar Syndrome Caused by Metronidazole
        A Patient with Typical Clinical Features of Mitochondrial Encephalopathy, Lactic Acidosis and Stroke-Like Episodes (MELAS) but Without an Obvious Genetic Cause: A Case Report
        Spinal Subdural Haematoma in Association With Anticoagulant Therapy, an Unusual Presentation. A Case Report and Review of Literature

        Cases archive
          




        my personal edition > neurologic other > news
        divider

          E-Mail this DGDispatch to a colleague

        DGDispatch


        Antiepilepsy Drug Levetiracetam (Keppra) Reduces Seizures in Brain Tumour Patients: Presented at AAN

        By Ed Susman

        MIAMI, FL -- April 13, 2005 -- Treatment with the anticonvulsant levetiracetam (Keppra) can prevent seizures among patients with malignant brain seizures and reduce the risk of drug-drug interactions that could compromise chemotherapy regimens.

        "Brain tumour patients are often on multiple medications and drug interactions can cause significant problems," said Glen Stevens, MD, section head of adult neuro-oncology, Cleveland Clinic, Cleveland, Ohio, United States.

        The study's findings were presented in a poster session here at the American Academy of Neurology 57th Annual Meeting.

        "For the past 3 years we have been converting our brain tumour patients who require anticonvulsants to levetiracetam (Keppra), which is a nonhepatic enzyme inducer," Dr. Stevens said. "We found levetiracetam to be well tolerated and an effective drug to control seizures in brain tumour patients."

        Dr. Stevens said that 70% of 278 patients were maintained on levetiracetam as monotherapy. Of patients treated with levetiracetam, 60% achieved a 50% reduction in seizure frequency.

        Similar results were observed in a separate study by Herbert Newton, MD, professor of neurology, paediatrics, and oncology, Arthur G. James Cancer Hospital and Richard J. Solove Research Institute, Ohio State University, Columbus, Ohio, United States.

        Dr. Newton also presented his study's findings at the AAN meeting.

        "We didn't look at whether treatment with levetiracetam improves outcomes such as mortality," Dr. Newton said, "but it is possible that by using a drug that doesn't interfere with chemotherapy we might be able to improve results."

        However, Dr. Newton said the study indicated a major improvement in quality of life for brain tumour patients by preventing seizures that occurred as infrequently as once a month to a frequently as 20 times a day. The average patient in his study had seizures about 3 times a day.

        "We saw an 87% reduction in seizures overall," said Samuel Goldlust, MD, a researcher at Ohio State who will begin an internship in May at New York University Medical School. "About 59% of our patients on levetiracetam were seizure free."

        The 41 patients in the Ohio State study included people who experienced seizures with primary brain cancers or patients with brain metastases.

        Levetiracetam appeared to produce somnolence in about 37% of patients, but patients did not have to come off the medication, Dr. Goldlust said.

        Dr. Stevens noted that levetiracetam is approved as add-on medication for patients with focal epilepsy. The drug is not metabolized by the cytochrome P-450 system and has no protein binding which makes it an excellent candidate for use in brain tumour patients.

        Further clinical trail will be needed before levetiracetam can be recommended as a first-line treatment in brain tumour patients, he said.


        [Presentation title: Retrospective Analysis of Levetiracetam for the Treatment of Seizures in Brain Tumor Patients. Abstract P65. Levetiracetam Use in Brain Tumor Patients. Abstract P66]



        E-Mail this DGDispatch to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send